|
A Director since January 2000, and elected Chairman of the Board of Directors in May 2005, Mr. Madden is a Founder and Principal with Narrow River Management, an investment management company with a focus on equity investments in the emerging pharmaceutical industry. Mr. Madden was Co-Chief Executive Officer of Royalty Pharma A.G., a private investment management firm specializing in the acquisition of royalty interests in pharmaceutical products, and Managing Member of its predecessor, Pharmaceutical Partners, LLC, from 1997 to 2003. From 1992 to 1995, Mr. Madden was President, Chief Executive Officer and a Director of Selectide Corporation, a development stage pharmaceutical company that was acquired by Marion Merrill Dow in 1995. Mr. Madden was a consultant to Marion Merrill Dow during part of 1995. Mr. Madden has a B.S. in Electrical Engineering from Union College and an M.B.A. from Columbia University. | 